| Articles Reviewed |
| 1: | Paul M Weinberger et al. Association of nuclear, cytoplasmic expression of galectin-3 with beta-catenin/Wnt-pathway activation in thyroid carcinoma. 2007 |
| 2: | Agoston T Agoston et al. Retinoblastoma pathway dysregulation causes DNA methyltransferase 1 overexpression in cancer via MAD2-mediated inhibition of the anaphase-promoting complex. 2007 |
| 3: | Liuqing Yang et al. Phosphorylation of p68 RNA helicase plays a role in platelet-derived growth factor-induced cell proliferation by up-regulating cyclin D1 and c-Myc expression. 2007 |
| 4: | Neeraj K Saxena et al. leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3. 2007 |
| 5: | Jiping Zhang et al. NFkappaB1/p50 is not required for tumor necrosis factor-stimulated growth of primary mammary epithelial cells: implications for NFkappaB2/p52 and RelB. 2007 |
| 6: | Irene Esposito et al. Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer. 2007 |
| 7: | Lanying Song et al. Essential functions of Alk3 during AV cushion morphogenesis in mouse embryonic hearts. 2007 |
| 8: | Nektarios Barabutis et al. Stimulation of proliferation of MCF-7 breast cancer cells by a transfected splice variant of growth hormone-releasing hormone receptor. 2007 |
| 9: | Jörg Weiske et al. The tumor suppressor Fhit acts as a repressor of beta-catenin transcriptional activity. 2007 |
| 10: | Maryline Paris et al. Homeodomain transcription factor Phox2a, via cyclic AMP-mediated activation, induces p27Kip1 transcription, coordinating neural progenitor cell cycle exit and differentiation. 2006 |
| 11: | Yanlin Yu et al. The homeoprotein six1 transcriptionally activates multiple protumorigenic genes but requires ezrin to promote metastasis. 2006 |
| 12: | Irina Groisman et al. Control of cellular senescence by CPEB. 2006 |
| 13: | Dan Lu et al. Activating transcription factor 3, a stress-inducible gene, suppresses Ras-stimulated tumorigenesis. 2006 |
| 14: | Mariko Tomita et al. Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells. 2006 |
| 15: | Hui Wang et al. Overexpression of ribosomal protein L15 is associated with cell proliferation in gastric cancer. 2006 |
| 16: | Sylvia M Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006 |
| 17: | Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |
| 18: | Laurence Bockstaele et al. Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors". 2006 |
| 19: | Patrice Delobel et al. Cell-cycle markers in a transgenic mouse model of human tauopathy: increased levels of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1. 2006 |
| 20: | Arnaud Besson et al. A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression. 2006 |
| 21: | C Juhlin et al. Loss of parafibromin expression in a subset of parathyroid adenomas. 2006 |
| 22: | Anja Duursma et al. p53-Dependent regulation of Cdc6 protein stability controls cellular proliferation. 2005 |
| 23: | Hong-Bing Ma et al. Association of cyclin D1, p16 and retinoblastoma protein expressions with prognosis and metastasis of gallbladder carcinoma. 2005 |
| 24: | Charles E Ducker et al. Two N-myristoyltransferase isozymes play unique roles in protein myristoylation, proliferation, and apoptosis. 2005 |
| 25: | Shravanti Rampalli et al. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex. 2005 |
| 26: | Jinyi Shao et al. Prostaglandin E2 Stimulates the beta-catenin/T cell factor-dependent transcription in colon cancer. 2005 |
| 27: | Pankaj Goyal et al. Inhibition of nuclear import of LIMK2 in endothelial cells by protein kinase C-dependent phosphorylation at Ser-283. 2005 |
| 28: | Cheng Zhang et al. PTEN represses RNA Polymerase I transcription by disrupting the SL1 complex. 2005 |
| 29: | Ramesh Sreeramaneni et al. Ras-Raf-Arf signaling critically depends on the Dmp1 transcription factor. 2005 |
| 30: | Eun-Joo Kim et al. IFI16 is an essential mediator of growth inhibition, but not differentiation, induced by the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells. 2005 |
| 31: | Nikos Tapinos et al. Insights into regulation of human Schwann cell proliferation by Erk1/2 via a MEK-independent and p56Lck-dependent pathway from leprosy bacilli. 2005 |
| 32: | Thorsten Maretzky et al. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. 2005 |
| 33: | Raju R Raval et al. Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. 2005 |
| 34: | Malika Hamdane et al. p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death. 2005 |
| 35: | Nichole Boyer Arnold et al. Smad7 abrogates transforming growth factor-beta1-mediated growth inhibition in COLO-357 cells through functional inactivation of the retinoblastoma protein. 2005 |
| 36: | Deepa Murali et al. Distinct developmental programs require different levels of Bmp signaling during mouse retinal development. 2005 |
| 37: | Nachman Mazurek et al. Phosphorylation of galectin-3 contributes to malignant transformation of human epithelial cells via modulation of unique sets of genes. 2005 |
| 38: | Olivier Nicole et al. Activation of protease-activated receptor-1 triggers astrogliosis after brain injury. 2005 |
| 39: | Chitkala Satyanarayana et al. DRF 3188 a novel semi-synthetic analog of andrographolide: cellular response to MCF 7 breast cancer cells. 2004 |
| 40: | Andrea G Lania et al. Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase a regulatory subunit 1A protein. 2004 |
| 41: | Lea Madi et al. The A3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition. 2004 |
| 42: | Ian Pitha-Rowe et al. Microarray analyses uncover UBE1L as a candidate target gene for lung cancer chemoprevention. 2004 |
| 43: | Vidya Mamidipudi et al. RACK1 regulates G1/S progression by suppressing Src kinase activity. 2004 |
| 44: | Sung-Kwon Moon et al. Disialoganglioside (GD3) synthase gene expression suppresses vascular smooth muscle cell responses via the inhibition of ERK1/2 phosphorylation, cell cycle progression, and matrix metalloproteinase-9 expression. 2004 |
| 45: | Tamar Golan et al. The human Frizzled 6 (HFz6) acts as a negative regulator of the canonical Wnt. beta-catenin signaling cascade. 2004 |
| 46: | Siwanon Jirawatnotai et al. Cdk4 is indispensable for postnatal proliferation of the anterior pituitary. 2004 |
| 47: | Seetharaman Balasenthil et al. p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells. 2004 |
| 48: | Takashi Suzuki et al. Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor. 2004 |
| 49: | Daniel G Rosen et al. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival. 2004 |
| 50: | N J Trudgill et al. Cell cycle regulation in patients with intestinal metaplasia at the gastro-oesophageal junction. 2003 |
| 51: | Chris Albanese et al. IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf. 2003 |
| 52: | Yu-Long Hu et al. Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells. 2003 |
| 53: | Lin Wang et al. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer. 2003 |
| 54: | Raphaëlle Romieu-Mourez et al. Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. 2003 |
| 55: | Marco Chilosi et al. Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis. 2003 |
| 56: | Roberto R Rosato et al. Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells. 2003 |
| 57: | Irene H L Hamelers et al. Insulin-like growth factor I triggers nuclear accumulation of cyclin D1 in MCF-7S breast cancer cells. 2002 |
| 58: | Luis M Schang et al. Explant-induced reactivation of herpes simplex virus occurs in neurons expressing nuclear cdk2 and cdk4. 2002 |
| 59: | Tadashi Yoshii et al. Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. 2002 |
| 60: | Cynthia C Sprenger et al. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis. 2002 |
| 61: | Heidi L Kenerson et al. Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors. 2002 |
| 62: | Cristina Broceño et al. RB activation defect in tumor cell lines. 2002 |
| 63: | Mihail S Iordanov et al. The UV (Ribotoxic) stress response of human keratinocytes involves the unexpected uncoupling of the Ras-extracellular signal-regulated kinase signaling cascade from the activated epidermal growth factor receptor. 2002 |
| 64: | Katsu Ishigaki et al. Aberrant localization of beta-catenin correlates with overexpression of its target gene in human papillary thyroid cancer. 2002 |
| 65: | Kevin A Walter et al. Scatter factor/hepatocyte growth factor stimulation of glioblastoma cell cycle progression through G(1) is c-Myc dependent and independent of p27 suppression, Cdk2 activation, or E2F1-dependent transcription. 2002 |
| 66: | Sandra Ciarallo et al. Altered p27(Kip1) phosphorylation, localization, and function in human epithelial cells resistant to transforming growth factor beta-mediated G(1) arrest. 2002 |
| 67: | Russell D Klein et al. Black tea polyphenols inhibit IGF-I-induced signaling through Akt in normal prostate epithelial cells and Du145 prostate carcinoma cells. 2002 |
| 68: | R G Hardy et al. Aberrant P-cadherin expression is an early event in hyperplastic and dysplastic transformation in the colon. 2002 |
| 69: | Avi Shvarts et al. A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling. 2002 |
| 70: | Yali Zhai et al. Role of beta-catenin/T-cell factor-regulated genes in ovarian endometrioid adenocarcinomas. 2002 |
| 71: | Catherine Kennedy et al. Cell proliferation in the normal mouse mammary gland and inhibition by phenylbutyrate. 2002 |
| 72: | Zhongfa Yan et al. Transforming growth factor beta 1 induces proliferation in colon carcinoma cells by Ras-dependent, smad-independent down-regulation of p21cip1. 2002 |
| 73: | K Kurose et al. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.. 2001 |
| 74: | B A Schmidt et al. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors. 2001 |
| 75: | Y Takasaki et al. Reactivity of anti-proliferating cell nuclear antigen (PCNA) murine monoclonal antibodies and human autoantibodies to the PCNA multiprotein complexes involved in cell proliferation. 2001 |
| 76: | M S Neshat et al. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. 2001 |
| 77: | A Schulze et al. Analysis of the transcriptional program induced by Raf in epithelial cells. 2001 |
| 78: | R A Campbell et al. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. 2001 |